To The Moon

$SUPER MICRO COMPUTER INC(SMCI)$ $Tesla Motors(TSLA)$ Bullish $NVIDIA(NVDA)$ Bullish I’m examining $SMCI through two frameworks right now, and they remain decisively out of sync. Price behaviour reflects fatigue after an extended contraction phase. Product architecture, hyperscale demand, and long-dated options positioning point toward deliberate accumulation. 🧭 Structure Check, Compression Before Commitment On the technical side, the 4H and 30-minute charts remain confined within descending Keltner and Bollinger bands, but the mechanics have changed. Volatility is compressing, lower bands are stabilising, and the $29 zone continues to absorb

🥂🍾👏🙌🥳 Huge congrats to @Barcode 👏📈. That $NVIDIA(NVDA)$ breakdown wasn’t flashy, it was precise. Clear downside mapping, volatility awareness and respect 🫡 for macro pressure points. Honestly your $Tesla Motors(TSLA)$ posts carried the same DNA 🚗⚡. This Top 10 spot feels fully earned!

$SPROTT JUNIOR COPPER MINERS ETF(COPJ)$ $SPDR Portfolio S&P 500 ETF(SPYM)$ $NEOS Nasdaq 100 High Income ETF(QQQI)$ I’m watching ETFs again. Not because I’m chasing beta, and not because I prefer simplification, but because ETFs are the earliest visible footprint of how institutions reposition before the broader narrative catches up. After decades watching capital flows dictate cycles, one principle holds. When ETF leadership changes, portfolios have already moved. That’s why this matters. Eric Balchunas at Bloomberg has published his “26 ETFs to Watch in

$Tesla Motors(TSLA)$ Bullish $Taiwan Semiconductor Manufacturing(TSM)$ Bullish $NVIDIA(NVDA)$ Bullish 31Dec25 🇺🇸 | 01Jan26 🇳🇿 I’m calling this market exactly as it traded, not as it was supposed to. The Grinch is no longer stealing Christmas, he’s cancelling it. The Santa Rally script failed, volatility took control, and $TSLA became the clearest expression of a regime shift that punished complacency and rewarded structure. That Grinch board isn’t satire. It’s a ledger. Happy New Year to all Tigers and traders 🎆 I’m stepping into 2026 focused on discipline, data, and positioning, not folklore. 🎅❌ Santa Rally Failure: When the Grinch

$S&P 500(.SPX)$ $Invesco QQQ(QQQ)$ $Meta Platforms, Inc.(META)$ 31Dec25 🇺🇸 | 01Jan26 🇳🇿 Market Pulse I’m closing the books on 2025 with a very clear message from price, breadth, and cross-asset behaviour. The final session was decisively risk-off, even as the year itself finished structurally strong. Markets closed red, with the $DJI, $SPX, and $IXIC logging a 4th straight daily loss. The Nasdaq slipped into the red for December, while the Dow notched its 8th straight monthly win. Still, all three capped a 3rd straight positive quarter and year, a classic late-cycle tell. Market breadth was decisively bearish to close the year. On the NYS

$APPLIED DIGITAL CORP(APLD)$ $Ekso Bionics(EKSO)$ $NVIDIA(NVDA)$ 30 Dec 2025 🇺🇸 | 31 Dec 2025 🇳🇿🥳 💻 97% retained ownership in a $75M GPU revenue platform, with AI compute valued on its own merits 🔍📐 This is a valuation reset driven by structure, not sentiment 📌 Key Numbers Snapshot, $APLD at a glance 💵 Price: ~$24.8 📈 YTD performance: +225% 🏗️ ChronoScale ownership: ~97% retained by $APLD 💻 Cloud revenue: ~$75.2M TTM (as of 31Aug25) 🧠 GPU footprint: 6 clusters, early $NVDA H100 deployment 📉 Open short interest: ~78.7M shares ⏳ Days to cover: ~3.0 📊 Daily shor

$Tesla Motors(TSLA)$ $Direxion Daily TSLA Bull 2X Shares(TSLL)$ $NIO Inc.(NIO)$ 🚨📊 Tesla Just Took Control of Wall Street’s Expectations 📊🚨📰 30 Dec 2025 🇺🇸 | 31 Dec 2025 🇳🇿🥳 I’m flagging this because it’s genuinely rare. 🚨📰 NEWS: Tesla has published street delivery estimates themselves, via a company-compiled sell-side

$Ultragenyx Pharmaceutical(RARE)$ $Spdr S&P Biotech Etf(XBI)$ $iShares Biotechnology ETF(IBB)$ 🧬🎯 Brittle Endpoint, Resilient Helix 🎯🧬 When a price cut sharpens the aim, not the thesis 🚨📰 Just in: $RARE proves you can put the target on a diet without starving the thesis. 🏦 Wells Fargo cut its price target on $RARE to $45 from $65 while maintaining Overweight. I read this as probability discipline, not loss of conviction. At roughly $19.72, the revised framework still implies about 128% upside, reframing the move as risk calibration rather than thesis erosion. ✂️ The reset followed Ultragenyx’s setrusumab miss in osteogenesis imperfecta, wh

$PulteGroup(PHM)$ $Toll Brothers(TOL)$ $Lennar(LEN)$ 📉🏗️📊 PHM Pullback Into the 320DMA, Noise or Opportunity? 📊🏗️📉 I’m watching PulteGroup $PHM ease about −1.2% as homebuilders cool after the hotter Case-Shiller print. That macro pressure is clear, but it’s also well flagged and broadly priced across the group. I’m far more interested in where price is landing. PHM is pulling back into its 320DMA around $117–118, a zone that has historically acted as a stabilisation area rather than a breakdown trigger. About half the time, tests of this long-term average have resolved higher, particularly when the broader trend structure remains intact. I’m no